Compounds > dilazep

dilazep and thromboplastin

dilazep has been researched along with thromboplastin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Deguchi, H; Gabazza, EC; Hayashi, N; Suzuki, K; Takeya, H; Urano, H; Wada, H1
Roubey, RA; Wolberg, AS; Zhou, H1
Zhou, H1

Other Studies

3 other study(ies) available for dilazep and thromboplastin

ArticleYear
Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes.
    Blood, 1997, Sep-15, Volume: 90, Issue:6

    Topics: Adenosine; Dilazep; Endothelium, Vascular; Gene Expression; Humans; Monocytes; Platelet Aggregation Inhibitors; Purinergic P1 Receptor Agonists; Tetradecanoylphorbol Acetate; Theophylline; Thrombin; Thromboplastin; Tumor Necrosis Factor-alpha

1997
Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep.
    Blood, 2004, Oct-15, Volume: 104, Issue:8

    Topics: Antibodies, Antiphospholipid; Antibodies, Monoclonal; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Blood Specimen Collection; Dilazep; Gene Expression Regulation; Glycoproteins; Humans; Immunoglobulin Fab Fragments; Immunoglobulin Fc Fragments; Immunoglobulin G; Lipopolysaccharides; Monocytes; RNA, Messenger; Thromboplastin; Time Factors

2004
Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
    Acta pharmacologica Sinica, 2004, Volume: 25, Issue:10

    Topics: Adrenergic Antagonists; Antiphospholipid Syndrome; Cell Separation; Dilazep; Dipyridamole; Gene Expression; Humans; Immunoglobulin G; Monocytes; Platelet Aggregation Inhibitors; RNA, Messenger; Theophylline; Thromboplastin

2004